A phase II study of continuous infusion 5‐fluorouracil in advanced hormone refractory prostate cancer. An illinois cancer center study Academic Article Article uri icon

Overview

MeSH Major

  • Magnetic Resonance Imaging
  • Neoplasms
  • Pelvis

abstract

  • Infusional 5-FU can not be recommended for the treatment of advanced hormone refractory prostate cancer.

publication date

  • January 1993

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1002/1097-0142(19930915)72:6<1965::AID-CNCR2820720629>3.0.CO;2-X

PubMed ID

  • 8364875

Additional Document Info

start page

  • 1965

end page

  • 8

volume

  • 72

number

  • 6